Get Consulting For Better Business Growth
Dapibus curae risus rutrum curabitur nunc sociis nullam nisl, aliquet quis iaculis scelerisque primis massa imperdiet, dis senectus blandit aptent nulla cubilia sodales convallis tortor pellentesque nulla.
Who We Are?
Core BI Solutions is based in Clearwater, Florida and Pune, India and was established in May 2023. We specialize in delivering high quality lead generation and other sales enabling functions for the life sciences services industry at highly affordable rates.
Originally established as a back office for CoreRx Pharma in May 2021, our parent company quickly realized the value proposition of various value-added services that were being provided, and wanted to evolve this business to serve other companies in the industry. The exciting journey for CoreBISolutions began!
Our primary service offering in lead generation is proven to help clients across industries such as CDMOs, CROs, Medical Devices, Analytical Testing Labs, Clinical Services, and Pharma/Biotech (and beyond!). We help our clients find greater sales success by helping them bring in more qualified leads and create a strong pipeline of opportunities through proven expertise-driven lead generation approaches. We support sales teams through cold calling, face-to-face customer meeting setup, customer meeting preparation and intelligence gathering, building territory roadmaps, and many other support functions. It’s not a ‘one-size fits all’ approach — our approach is proven to increase your sales pipeline in a way that works with the style and culture of your organization.
Over the last few years, we have set the highest level of standards for sales enablement. Our aim is to continue delivering unparalleled value to our clients.
We have recently expanded our B2B service offering beyond lead generation, including:
- Marketing
- Finance / Back office
- ERP
- Project Management
- CRM support
Why Core BI Solutions?
- Proven track record of delivering value in new client acquisition and brand awareness for our clients.
- High value, yet extremely cost-effective solution to acquire new customers.
- Quick start of the assignment immediately upon signing the contract. No long waiting period means faster results for our clients.
- Asset light model, which means no need to own an office, hire separate employees or buy any tools. Our experts come on board with these professional tools to deliver results for the customer.
- Process oriented, expertise driven and highly professional approach towards new client acquisition techniques.
- We work closely and respectfully with our client’s sales team to build effective territory plans, which help generate a strong pipeline of opportunities without experiencing any conflict at work.
- Diverse experience of working across the life science industry (pharma, biotech, medical devices, clinical, regulatory, GxP compliance and analytical testing service provider companies etc)
Let’s discuss about how we can help make your business better
Leadership Team
Ajay Damani
Chief Executive OfficerAjay Damani, CEO of Group CoreRx and Board member since October 2021, has 20+ years in life sciences, specializing in sales, marketing, M&A, licensing, and product development. He led Adare Pharmaceuticals' Pharmaceutical Technologies unit and played a key role in Capsugel's Global Pharmaceutical Business Development, overseeing commercial integration after its acquisition by Lonza. Ajay holds dual degrees from the University of Pennsylvania in Engineering and Applied Science and the Wharton School of Business.
Nailesh Bhatt
Board MemberWith over 25 years in the pharmaceutical industry, Nailesh Bhatt is a serial entrepreneur, serving as the Founder and CEO of VGYAAN Pharmaceuticals and the Founder and Managing Director of Proximare, a strategic advisory firm. His entrepreneurial journey includes founding BulkDrugs.com. Nailesh has held various roles at companies like Sidmak Laboratories, SEPPIC, and Arthur Andersen. Currently, he is a Board member for Azurity Pharmaceuticals, CoreRx Pharma, Spectra Medical Devices, Sonnet BioTherapeutics (NASDAQ: SONN), and VGYAAN Pharmaceuticals.
Aniket Manathkar
General ManagerAniket is a seasoned techno-commercial expert, boasts 14+ years in the bio-pharmaceutical industry, excelling in Business Development, and R&D. He has earned his B. Pharmacy in India, a Master's in Pharmaceutical Sciences from the University of Greenwich, UK, and an International Executive MBA from United Business Institutes, Belgium. With a diverse career spanning start-ups to Big-Pharma in India, he previously led the Inside Sales Team at Syngene International, promoting global drug discovery and manufacturing services. Aniket's expertise encompasses a broad portfolio, including CRAMS, drug discovery, compliance, and project management, complemented by a passion for travel, and financial management.
WE ARE EXPERIENCED
Business Solution
Customer Feeback / Testimonials
Pharma CDMO (US based)
"CoreBISolutions is playing a key role in brand awareness of the company in the US and beyond. In a very short time span of engagement, we have seen great success in securing potential customer meetings to promote our CDMO services. CoreBISolutions also help us set up CRM processes align our entire commercial team through our CRM."
Medical Device Company (US based)
“We are delighted with the work CoreBISolutions has done for us on helping us prioritize & align our business development efforts.”
Pharmaceutical CDMO (US based)
“We use CoreBISolutions for our inside sales and business development support. We have increased our number of customer visits during roadshows by at least 30%., and we are better prepared for customer meetings than we have ever been in the past."
Medical Device Company (US based)
“CoreBISolutions performed key secondary market research for the identified set of M&A targets that helped us get a greater understanding on which targets were good strategic fits."
Pharmaceutical CDMO (US based)
“We use CoreBISolutions for finance and back office support. We have experienced cost savings over $1M annually, and the quality of these functions are operating at a higher level than before."